» Articles » PMID: 36594366

Innovation and Renovation: FEBS Open Bio in 2023

Overview
Journal FEBS Open Bio
Specialty Biology
Date 2023 Jan 3
PMID 36594366
Authors
Affiliations
Soon will be listed here.
Abstract

FEBS Open Bio is constantly evolving to best suit the needs of the scientific community. In this Editorial, we review the various new initiatives introduced in 2022 and look forward to the opportunities and challenges that lie ahead in 2023.

References
1.
Watts C . Lysosomes and lysosome-related organelles in immune responses. FEBS Open Bio. 2022; 12(4):678-693. PMC: 8972042. DOI: 10.1002/2211-5463.13388. View

2.
Mion D, Bunel L, Heo P, Pincet F . The beginning and the end of SNARE-induced membrane fusion. FEBS Open Bio. 2022; 12(11):1958-1979. PMC: 9623537. DOI: 10.1002/2211-5463.13447. View

3.
Rethi-Nagy Z, Abraham E, Lipinszki Z . GST-IVTT pull-down: a fast and versatile in vitro method for validating and mapping protein-protein interactions. FEBS Open Bio. 2022; 12(11):1988-1995. PMC: 9623517. DOI: 10.1002/2211-5463.13485. View

4.
Caceres C, Seibert B, Cargnin Faccin F, Cardenas-Garcia S, Rajao D, Perez D . Influenza antivirals and animal models. FEBS Open Bio. 2022; 12(6):1142-1165. PMC: 9157400. DOI: 10.1002/2211-5463.13416. View

5.
Qiao S, Zhang S, Ge J, Wang X . The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition. FEBS Open Bio. 2022; 12(9):1602-1622. PMC: 9433818. DOI: 10.1002/2211-5463.13454. View